Jefferson Innovation Engagement Speaker Series 2020

Jefferson Innovation Engagement Speaker Series 2020

Jefferson brings to you a diverse group of Business, Academic, Foundation and Thought Leaders each year whose work pushes innovation!

By Jefferson Innovation

Date and time

January 23, 2020 · 11:45am - April 16, 2020 · 1pm EST

Location

Thomas Jefferson University

901 Walnut Street First Floor Lobby Philadelphia, PA 19107

About this event

Event Summary

The Innovation Engagement Speaker Series at Jefferson is aimed at exploring multiple aspects of innovation as it is developing at Jefferson and beyond. The focus includes local, regional and national perspectives, with topics ranging from start-up challenges, innovation across the Jefferson enterprise, venture capital, and prototype generation. Whether you are a clinician, researcher, nascent inventor, entrepreneur or just a curious mind, attendees will walk away with something of value.

  • Lunch will be served
  • This event is open to all
  • Recorded sessions will be uploaded within a week to YouTube.

2020 Lineup

January 23 - Steve Altschuler MD

Chair - Board of Directors, Spark Therapeutics

  • The Spark in SPARK: Early History

January 30 - Shahram Hejazi PhD & Rick Jones MD, MBA

Partners with BioAdvance

  • Angel Seed and Venture Capital: A 2020 Snapshot

February 6 - Sharon Pinkenson

Executive Director, Greater Philadelphia Film Office

  • Lights, Camera, Action: Filming in Philly

February 13 - Todd Carmichael

CEO and Co-Founder, La Colombe Coffee Roasters

  • Barista to a Billion - My Journey and What I've learned so far

February 20 - Hope D'Oyley-Gay, JD

General Counsel and Vice President of Administration, Spirovant Sciences, Inc.

  • Innovation and Business Development

February 27 - Karen Keating Mara, Esq.

Managing Member, Keating Mara & Associates

  • So you want to do a start up? Legal Considerations

March 19 - Parviz Shamlou, PhD

This engagement is canceled. Apologies for the inconvenience.

Executive Director, Jefferson Institute for Bioprocessing

  • Building the Bioprocessing Foundation for Advanced Therapies at TJU

March 26 - Matthias J. Schnell, PhD

Department Chair, Microbiology and Immunology, Director Jefferson Vaccine Center, Sidney Kimmel Medical College at Thomas Jefferson University

  • COVID-19: Virology of the Pandemic

April 9 - Edmund Pribitkin MD, MBA, FACS

President, Jefferson Medical Group; CMO, Thomas Jefferson University

  • From Concept to Prototype

April 16 - Michael Rubin

Executive Chairman, Fanatics; Partner, Philadelphia 76ers; Co-Chair, REFORM Alliance

  • Entrepreneurship and Social Justice; Opportunities and Responsibilities

Organized by

Sales Ended